EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
15.46
-0.29 (-1.84%)
Mar 9, 2026, 2:25 PM EDT - Market open
EyePoint Employees
EyePoint had 214 employees as of December 31, 2025. The number of employees increased by 49 or 29.70% compared to the previous year.
Employees
214
Change (1Y)
49
Growth (1Y)
29.70%
Revenue / Employee
$190,127
Profits / Employee
-$1,405,830
Market Cap
1.29B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 645 |
| Precigen | 143 |
| MoonLake Immunotherapeutics | 130 |
| Olema Pharmaceuticals | 122 |
| Taysha Gene Therapies | 73 |
| Savara | 59 |
| AtaiBeckley | 54 |
| MBX Biosciences | 43 |
EYPT News
- 4 days ago - EyePoint, Inc. (EYPT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - EyePoint Reports Fourth Quarter and Full-Year 2025 Financial Results and Highlights Recent Corporate Developments - GlobeNewsWire
- 7 days ago - EyePoint Announces First Patients Dosed in Both Global Phase 3 Clinical Trials of DURAVYU™ for the Treatment of Diabetic Macular Edema - GlobeNewsWire
- 12 days ago - EyePoint to Report Fourth Quarter and Full-Year 2025 Financial Results on March 4, 2026 - GlobeNewsWire
- 13 days ago - EyePoint Announces Participation at Upcoming Investor Conferences - GlobeNewsWire
- 19 days ago - EyePoint Appoints Michael Campbell as Chief Commercial Officer - GlobeNewsWire
- 20 days ago - EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - EyePoint to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire